Matches in Nanopublications for { ?s ?p "[Sensitivity of the prostate cancer antigen 3 test could be improved by the detection of the fusion gene transcripts transmembrane protease serine 2-E26 transformation specific-related gene and serine peptidase inhibitor Kazal type 1 who may in addition allow the identification of prostate cancer patients at higher risk of life-threatening disease.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP903161.RAmYMwMoRkVP3THcHppw8kdCh4quZ3rlIVkCFYwf56MuM130_assertion description "[Sensitivity of the prostate cancer antigen 3 test could be improved by the detection of the fusion gene transcripts transmembrane protease serine 2-E26 transformation specific-related gene and serine peptidase inhibitor Kazal type 1 who may in addition allow the identification of prostate cancer patients at higher risk of life-threatening disease.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP903161.RAmYMwMoRkVP3THcHppw8kdCh4quZ3rlIVkCFYwf56MuM130_provenance.
- NP749405.RApkIO8zHCl0Vpu2cipFZNTcdZJmnChFuv_18VdXbyXgE130_assertion description "[Sensitivity of the prostate cancer antigen 3 test could be improved by the detection of the fusion gene transcripts transmembrane protease serine 2-E26 transformation specific-related gene and serine peptidase inhibitor Kazal type 1 who may in addition allow the identification of prostate cancer patients at higher risk of life-threatening disease.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP749405.RApkIO8zHCl0Vpu2cipFZNTcdZJmnChFuv_18VdXbyXgE130_provenance.
- NP710486.RAVALiY8zWTtxIDYdphZwCtlNoUtuUOhZY-pFRgzNaLso130_assertion description "[Sensitivity of the prostate cancer antigen 3 test could be improved by the detection of the fusion gene transcripts transmembrane protease serine 2-E26 transformation specific-related gene and serine peptidase inhibitor Kazal type 1 who may in addition allow the identification of prostate cancer patients at higher risk of life-threatening disease.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP710486.RAVALiY8zWTtxIDYdphZwCtlNoUtuUOhZY-pFRgzNaLso130_provenance.
- NP728798.RAczh5V1X9Cmh1UZsGrmb6_33wJt2UulYn_9LRczrfYf0130_assertion description "[Sensitivity of the prostate cancer antigen 3 test could be improved by the detection of the fusion gene transcripts transmembrane protease serine 2-E26 transformation specific-related gene and serine peptidase inhibitor Kazal type 1 who may in addition allow the identification of prostate cancer patients at higher risk of life-threatening disease.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP728798.RAczh5V1X9Cmh1UZsGrmb6_33wJt2UulYn_9LRczrfYf0130_provenance.
- NP710471.RAsWxEm4PFgHHk3FCB8GRe4I_7MnQj4x-SshjH7wOoNa8130_assertion description "[Sensitivity of the prostate cancer antigen 3 test could be improved by the detection of the fusion gene transcripts transmembrane protease serine 2-E26 transformation specific-related gene and serine peptidase inhibitor Kazal type 1 who may in addition allow the identification of prostate cancer patients at higher risk of life-threatening disease.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP710471.RAsWxEm4PFgHHk3FCB8GRe4I_7MnQj4x-SshjH7wOoNa8130_provenance.
- NP728797.RAx_7FwrPmpeTxLL5_Ho_eGNgmo-osmRB5JW95LxzC1oc130_assertion description "[Sensitivity of the prostate cancer antigen 3 test could be improved by the detection of the fusion gene transcripts transmembrane protease serine 2-E26 transformation specific-related gene and serine peptidase inhibitor Kazal type 1 who may in addition allow the identification of prostate cancer patients at higher risk of life-threatening disease.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP728797.RAx_7FwrPmpeTxLL5_Ho_eGNgmo-osmRB5JW95LxzC1oc130_provenance.